Value of Blood Count–Derived Inflammatory Markers for Evaluating Psoriasis Severity: Pilot Cross-Sectional Observational Study
Interactive Journal of Medical Research · 14.05.2026 · 15 · e86454-e86454
DOI: 10.2196/86454 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Interactive Journal of Medical Research, online erschienen am 14.05.2026. Verfasst von Luyuan Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, Guangxi, China. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Objective indicators are urgently needed to evaluate and monitor disease progression in patients with psoriasis.
Objective
This study aimed to verify the correlations between blood count–derived inflammatory markers and the Psoriasis Area and Severity Index (PASI) among patients with psoriasis and explore the value of applying the PASI in combination with proinflammatory factors.
Methods
This was a cross-sectional observational study that enrolled 719 patients from 2 tertiary hospitals. Receiver operating characteristic curve analysis and binary logistic regression models were applied to assess the evaluative power of blood count–derived inflammatory markers and their consistency with the PASI for stratifying psoriasis severity. The association with the PASI and the combination with proinflammatory factors of the blood count–derived inflammatory markers in 60 patients were analyzed. The exploratory association between blood count–derived markers and proinflammatory factors was analyzed using product terms. To ensure robustness, multivariable combined models were evaluated using receiver operating characteristic curves and decision curve analysis. Model performance was further validated via calibration plots and a predictive nomogram, with the decision curve analysis net benefit axis increased to 1.0 for comprehensive visualization.
Results
The area under the curve showed that the systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and aggregate index of systemic inflammation (AISI) were effective in reflecting psoriasis severity and showed advantages in patients with psoriasis complicated by arthritis and cardiovascular metabolic diseases. The comprehensive test showed quite appropriate consistency of the SIRI and PASI in distinguishing severity. The SII, SIRI, and AISI were significantly correlated with interleukin (IL)-6 in lesions (all P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology and Venereology, Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, Guangxi, China.
- First Clinical Medical College, Guangxi Medical University, Nanning, Guangxi, China.
- Department of Dermatology and Venereology, First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Road, Nanning, Guangxi, 530021, China, 86 0771-5356514.
Zitieren
APA
Wang, L., Zhang, X., Xia, C., Li, W., Li, Q., Xiao, W., & Lin, Y. (2026). Value of Blood Count–Derived Inflammatory Markers for Evaluating Psoriasis Severity: Pilot Cross-Sectional Observational Study. Interactive Journal of Medical Research, 15, e86454-e86454. https://doi.org/10.2196/86454
Vancouver
Wang L, Zhang X, Xia C, Li W, Li Q, Xiao W, et al. Value of Blood Count–Derived Inflammatory Markers for Evaluating Psoriasis Severity: Pilot Cross-Sectional Observational Study. Interactive Journal of Medical Research. 2026;15:e86454-e86454. doi:10.2196/86454
BibTeX
@article{Wang2026,
author = {Wang, Luyuan and Zhang, Xiaorui and Xia, Chuangang and Li, Wenyu and Li, Qiuju and Xiao, Wen and Lin, Youkun},
title = {Value of Blood Count–Derived Inflammatory Markers for Evaluating Psoriasis Severity: Pilot Cross-Sectional Observational Study},
journal = {Interactive Journal of Medical Research},
year = {2026},
volume = {15},
pages = {e86454--e86454},
doi = {10.2196/86454}
}
EUVIMED